Search Results for “”

Episode 64: Cognitive Neuropsychiatric Symptoms in Lupus with Dr. Zahi Touma

Oct 02, 2026

CRA Board of Directors – Member-at-Large

The Canadian Rheumatology Association (CRA) is inviting nominations for upcoming vacancies on its Board of Directors, effective April 2027.

Aug 10, 2026

Chart Audit Library

Refer to the links below for various tools to perform an audit and earn Section 3 credits.

Jul 28, 2026

Healthcare Inequities in Rheumatology Webinar Series

The CRA, as part of its commitment to Equity, Diversity and Inclusion, has launched a special project to discuss healthcare inequities in Rheumatology. This project is provided as a webinar series that has been developed based on feedback from CRA […]

Jul 24, 2026

Abstracts Presented in 2026

Abstracts Presented at the CRA Annual Scientific Meeting in Halifax, Nova Scotia, April 16 – 19, 2026

Jul 24, 2026

Educational Resources

This section features resources the CRA feels will be of interest to members.

Jul 24, 2026

Indigenous Health Resources

Participant-reported effect of an Indigenous Health continuing professional development initiative for specialists Health outcomes of Indigenous patients are impacted by culturally unsafe specialty care environments. The ‘Educating for Equity (E4E)’ program is a continuing professional development (CPD) intervention which incorporates […]

Jul 24, 2026

Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis in Canada

The Canadian Scleroderma Research Group teamed up with the Australian Scleroderma Interest Group to developed a new set of inclusion/exclusion criteria for stem cell transplantation that can act as guide to Canadian rheumatologists. The criteria were based on the results […]

Jul 24, 2026

Annual Report

This report will provide a brief summary of what we, at the CRA, have been up to thanks primarily to our committed members and the support of our partners and friends.

Jul 24, 2026

CRA living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs

This Canadian Rheumatology Association (CRA) guideline provides contemporary recommendations for the pharmacological management of rheumatoid arthritis (RA) with disease-modifying anti-rheumatic drug (DMARD) therapy. Recommendations are developed using the GRADE approach with a multidisciplinary panel composed of rheumatologists, researchers, methodologists, and […]

Apr 23, 2026